- Home
- KOSS vs VRCA Comparison
KOSS vs VRCA Comparison
Compare KOSS & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- VRCA
- Stock Information
- Founded
- KOSS 1953
- VRCA 2013
- Country
- KOSS United States
- VRCA United States
- Employees
- KOSS N/A
- VRCA N/A
- Industry
- KOSS Consumer Electronics/Appliances
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- KOSS Consumer Staples
- VRCA Health Care
- Exchange
- KOSS Nasdaq
- VRCA Nasdaq
- Market Cap
- KOSS 39.9M
- VRCA 43.0M
- IPO Year
- KOSS N/A
- VRCA 2018
- Fundamental
- Price
- KOSS $5.82
- VRCA $0.49
- Analyst Decision
- KOSS
- VRCA Hold
- Analyst Count
- KOSS 0
- VRCA 5
- Target Price
- KOSS N/A
- VRCA $6.00
- AVG Volume (30 Days)
- KOSS 106.4K
- VRCA 263.8K
- Earning Date
- KOSS 05-08-2025
- VRCA 05-13-2025
- Dividend Yield
- KOSS N/A
- VRCA N/A
- EPS Growth
- KOSS N/A
- VRCA N/A
- EPS
- KOSS N/A
- VRCA N/A
- Revenue
- KOSS $12,433,361.00
- VRCA $7,179,000.00
- Revenue This Year
- KOSS N/A
- VRCA $127.85
- Revenue Next Year
- KOSS N/A
- VRCA $105.09
- P/E Ratio
- KOSS N/A
- VRCA N/A
- Revenue Growth
- KOSS N/A
- VRCA N/A
- 52 Week Low
- KOSS $3.81
- VRCA $0.38
- 52 Week High
- KOSS $18.73
- VRCA $9.36
- Technical
- Relative Strength Index (RSI)
- KOSS 57.34
- VRCA 42.86
- Support Level
- KOSS $5.61
- VRCA $0.49
- Resistance Level
- KOSS $6.48
- VRCA $0.73
- Average True Range (ATR)
- KOSS 0.51
- VRCA 0.07
- MACD
- KOSS 0.06
- VRCA -0.01
- Stochastic Oscillator
- KOSS 47.40
- VRCA 21.79
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.